Committees:
- ESG
- Human Resources and Compensation
Attributes and skills:
- Leadership experience in life sciences and healthcare companies
- Global business experience
- Risk management and investment stewardship
- Growth strategies and market expansion
- Experience in highly regulated industries
Expertise provided to the Board:
Michael Rosenblatt, MD has deep leadership and executive experience in the biotechnology industry, including as the chief medical officer of a major pharmaceutical company and at a substantial life sciences investment firm. He also has deep board-level and management team experience as a founding scientist, scientific advisory Board member, director of more than a dozen biopharmaceutical companies and Board member during the Company’s transition from Brooks Automation to Azenta Life Sciences. Further, thanks to his academic leadership experience as a dean and professor at prestigious medical schools and as a leader in the biotech industry, including as a winner of the Fuller Albright Award, he has extensive expertise in drug discovery and medical research, bringing unique industry insights to the Azenta Board, particularly as it relates to the customer perspective, research and development, as well as opportunities in the marketplace.